Administration of Autologous Bone Marrow-Derived Stem Cells for Treatment of Cerebral Palsy Patients: A Proof of Concept.

Conclusion: Our results indicated that bone marrow derived MNCs are safe and effective for the treatment of motor deficits related to cerebral palsy. Further randomized clinical trials are necessary to establish the efficacy of this procedure. PMID: 28296863 [PubMed - in process]
Source: Journal of Stem Cells - Category: Stem Cells Tags: J Stem Cells Source Type: research